Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Decoding the PITX2-controlled genetic network in atrial fibrillation
Jeffrey D. Steimle, Francisco J. Grisanti Canozo, Minjun Park, Zachary A. Kadow, Md. Abul Hassan Samee, James F. Martin
Jeffrey D. Steimle, Francisco J. Grisanti Canozo, Minjun Park, Zachary A. Kadow, Md. Abul Hassan Samee, James F. Martin
View: Text | PDF
Resource and Technical Advance Cardiology

Decoding the PITX2-controlled genetic network in atrial fibrillation

  • Text
  • PDF
Abstract

Atrial fibrillation (AF), the most common sustained cardiac arrhythmia and a major risk factor for stroke, often arises through ectopic electrical impulses derived from the pulmonary veins (PVs). Sequence variants in enhancers controlling expression of the transcription factor PITX2, which is expressed in the cardiomyocytes (CMs) of the PV and left atrium (LA), have been implicated in AF predisposition. Single nuclei multiomic profiling of RNA and analysis of chromatin accessibility combined with spectral clustering uncovered distinct PV- and LA-enriched CM cell states. Pitx2-mutant PV and LA CMs exhibited gene expression changes consistent with cardiac dysfunction through cell type–distinct, PITX2-directed, cis-regulatory grammars controlling target gene expression. The perturbed network targets in each CM were enriched in distinct human AF predisposition genes, suggesting combinatorial risk for AF genesis. Our data further reveal that PV and LA Pitx2-mutant CMs signal to endothelial and endocardial cells through BMP10 signaling with pathogenic potential. This work provides a multiomic framework for interrogating the basis of AF predisposition in the PVs of humans.

Authors

Jeffrey D. Steimle, Francisco J. Grisanti Canozo, Minjun Park, Zachary A. Kadow, Md. Abul Hassan Samee, James F. Martin

×

Figure 4

Human AF GWAS enrichment in perturbed PITX2 networks.

Options: View larger image (or click on image) Download as PowerPoint
Human AF GWAS enrichment in perturbed PITX2 networks.
(A) Enrichment sco...
(A) Enrichment scores of normalized and binned gene expression by cell subset for AF GWAS–associated genes. (B) Example AF-SNP loci (arrows) with coding genes within the 1 Mb window demonstrating top 20th percentile enrichment in CM1 (orange), CM2 (green), CM3 (red), or adipocytes (blue. (C) Venn diagram comparing the overlapping AF SNPs associated with at least 1 highly cell type–enriched gene (20th percentile). A total of 22 SNPs were not associated with any of the 4 cell types by our method. (D) Venn diagram comparing the 20th percentile cell type–enriched genes underlying the SNPs in C. (E) Enrichment scores by Fisher’s exact test for the overlap of previously identified Pitx2-dependent genes in CMs and adipocytes with the SNP-associated, cell type–enriched genes identified in D. Adjusted P value (FDR) for each enrichment test shown.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts